1,261
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and Pharmacodynamics of Sterylglucoside-Modified Liposomes for Levonorgestrel Delivery via Nasal Route

, , &
Pages 101-104 | Received 02 Dec 2005, Accepted 19 Feb 2006, Published online: 10 Oct 2008

Figures & data

FIG. 1 Mean levonorgestrel plasma concentrations versus time profiles for oral and nasal administration (mean ± SD, n = 4). ♦-LNG suspension by oral administration at 500 μg/rat; ▴-EPC/SG/LNG by nasal administration at 500 μg/rat; ▵-EPC/SG/LNG/chitosan by nasal administration at 500 μg/rat; •-EPC/SG/LNG by nasal administration at 350 μg/rat; ▪-EPC/Ch/LNG by nasal administration at 350 μg/rat.

FIG. 1 Mean levonorgestrel plasma concentrations versus time profiles for oral and nasal administration (mean ± SD, n = 4). ♦-LNG suspension by oral administration at 500 μg/rat; ▴-EPC/SG/LNG by nasal administration at 500 μg/rat; ▵-EPC/SG/LNG/chitosan by nasal administration at 500 μg/rat; •-EPC/SG/LNG by nasal administration at 350 μg/rat; ▪-EPC/Ch/LNG by nasal administration at 350 μg/rat.

TABLE 1 Pharmacokinetic parameters of different levonorgestrel (LNG) formulations after oral or nasal administration in rats*

TABLE 2 Contraceptive effects with different levonorgestrel (LNG) formulations

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.